Back to search

Article

Unearthing New Genomic Markers of Drug Response by Improved Measurement of Discriminative Power

2015-11-27

Abstract excerpt

<h4>Background</h4> Oncology drugs are only effective in a small proportion of cancer patients. Our current ability to identify these responsive patients before treatment is still poor in most cases. Thus, there is a pressing need to discover response markers for marketed and research oncology drugs in order to improve patient survival, reduce healthcare costs and enhance success rates in clinical trials. Screeni...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bd192c78-8410-547b-a13c-4ffae5354266
DOI
10.1101/033092
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Unearthing New Genomic Markers of Drug Response by Improved Measurement of Discriminative PowerDOI 10.1101/033092
Systematic assessment of multi-gene predictors of pan-cancer cell line sensitivity to drugs exploiting gene expression dataSemantic proximity
Integrative Statistical Inferences for Drug Sensitivity Biomarkers in CancerSemantic proximity
Precision and recall oncology: combining multiple gene mutations for improved identification of drug-sensitive tumoursSemantic proximity
Systematic assessment of multi-gene predictors of pan-cancer cell line sensitivity to drugs exploiting gene expression dataSemantic proximity
Assessment of pharmacogenomic agreementSemantic proximity
Drug Sensitivity Prediction From Cell Line-Based Pharmacogenomics Data: Guidelines for Developing Machine Learning ModelsSemantic proximity
Assessment of pharmacogenomic agreementSemantic proximity
Robust and clinically relevant prediction of response to anti-cancer drugs via network integration of molecular profilesSemantic proximity
Machine learning models to predict <i>in vivo</i> drug response via optimal dimensionality reduction of tumour molecular profilesSemantic proximity
A Clear, Legible, Explainable, Transparent, and Elucidative (CLETE) Binary Classification Platform for Tabular DataSemantic proximity
Machine Learning Assisted Web Application for Identifying Beneficial Drug Candidates for Genetic Alterations in Cancer PatientsSemantic proximity
Strategies to design clinical studies to identify predictive biomarkers in cancer research.Semantic proximity
Select a neighboring publication to make it the new centre.